← Leaderboards
Dominique S Michaud
Harvard University (Sch Of Public Hlth)
$6,596,308
Attributed
$8,655,688
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $805K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,655,688 · 8
By mechanism
R01$7,491,688 · 4
R21$833,064 · 2
R03$330,936 · 2
Top collaborators
- Jacques G Izard5 shared
- Yen-Tsung Huang3 shared
- Karl T Kelsey3 shared
Most similar at Harvard University (Sch Of Public Hlth)
Same institution · by research overlap
- Walter C. Willett$98,918,122
- Rebecca A. Betensky$13,417,517
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsBlood SpecimenBloodDiagnosisSamplingEtiologyCase ControlPlasmaImmuneBaseCohortRisk FactorsTissuesDesignReportingEpidemiologic StudiesPreventionCancer RiskAccountingMolecularFutureDiagnosticHealth ProfessionalCohort Studies
Grant awards (24)
Improving risk stratification for lung cancer screening using peripheral blood leukocyte DNA methylation: an investigation in the National Lung Screening Trial (NLST)$676,338
R01 · FY2025 · CA · contact PI
Improving risk stratification for lung cancer screening using peripheral blood leukocyte DNA methylation: an investigation in the National Lung Screening Trial (NLST)$722,370
R01 · FY2024 · CA · contact PI
Circulating Antibodies to Oral Microbiota and Colon Cancer Risk$143,177
R21 · FY2020 · CA · contact PI
Circulating Antibodies to Oral Microbiota and Colon Cancer Risk$250,540
R21 · FY2019 · CA · contact PI
Prospective immune profiling using methylation markers and pancreatic cancer risk$674,455
R01 · FY2018 · CA · contact PI
Prospective immune profiling using methylation markers and pancreatic cancer risk$804,995
R01 · FY2017 · CA · contact PI
Prospective immune profiling using methylation markers and pancreatic cancer risk$617,928
R01 · FY2016 · CA · contact PI
Microbiomes in Human Pancreatic Cancer$630,157
R01 · FY2015 · CA · contact PI
Integrative Modeling of Gene Expression into GWAS of Glioma$85,071
R03 · FY2015 · CA · contact PI
Microbiomes in Human Pancreatic Cancer$513,282
R01 · FY2014 · CA · contact PI
Microbiomes in Human Pancreatic Cancer$188,685
R01 · FY2014 · CA · contact PI
Integrative modeling of gene expression into GWAS of glioma$41,250
R03 · FY2014 · CA · contact PI
Integrative Modeling of Gene Expression into GWAS of Glioma$40,615
R03 · FY2014 · CA · contact PI
Microbiomes in Human Pancreatic Cancer$713,133
R01 · FY2013 · CA · contact PI
Allergies, Genetic Susceptibility and Adult Glioma Risk$403,962
R01 · FY2011 · CA · contact PI
SEROLOGICAL MARKERS OF PERIODONTAL DISEASE AND PANCREATIC CANCER RISK$192,122
R21 · FY2011 · CA · contact PI
SEROLOGICAL MARKERS OF PERIODONTAL DISEASE AND PANCREATIC CANCER RISK$247,225
R21 · FY2010 · CA · contact PI
Allergies, Genetic Susceptibility and Adult Glioma Risk$1
R01 · FY2010 · CA · contact PI
Allergies, Genetic Susceptibility and Adult Glioma Risk$406,175
R01 · FY2009 · CA · contact PI
Allergies, Genetic Susceptibility and Adult Glioma Risk$371,078
R01 · FY2008 · CA · contact PI
Allergies, Genetic Susceptibility and Adult Glioma Risk$399,509
R01 · FY2007 · CA · contact PI
Allergies, Genetic Susceptibility and Adult Glioma Risk$369,620
R01 · FY2006 · CA · contact PI
A prospective study of diet and adult gliomas$82,000
R03 · FY2005 · CA
A prospective study of diet and adult gliomas$82,000
R03 · FY2004 · CA